222 related articles for article (PubMed ID: 12210228)
21. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].
Sáiz A; Marín C; Tolosa E; Graus F
Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794
[TBL] [Abstract][Full Text] [Related]
23. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
[TBL] [Abstract][Full Text] [Related]
24. Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease.
Martindale J; Geschwind MD; De Armond S; Young G; Dillon WP; Henry R; Uyehara-Lock JH; Gaskin DA; Miller BL
Arch Neurol; 2003 May; 60(5):767-70. PubMed ID: 12756143
[TBL] [Abstract][Full Text] [Related]
25. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
[TBL] [Abstract][Full Text] [Related]
26. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
[TBL] [Abstract][Full Text] [Related]
27. Cellular immune activation markers neopterin and β2-microglobulin are not elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Stoeck K; Zerr I
J Neuroimmunol; 2011 Apr; 233(1-2):228-32. PubMed ID: 21232804
[TBL] [Abstract][Full Text] [Related]
28. ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients.
Steinacker P; Klafki H; Lehnert S; Jesse S; Arnim CA; Tumani H; Pabst A; Kretzschmar HA; Wiltfang J; Otto M
J Alzheimers Dis; 2010; 22(1):119-28. PubMed ID: 20847405
[TBL] [Abstract][Full Text] [Related]
29. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
Bernheimer H; Gatterbauer B; Radbauer C; Budka H
Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
[TBL] [Abstract][Full Text] [Related]
30. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.
Burgess JA; Lescuyer P; Hainard A; Burkhard PR; Turck N; Michel P; Rossier JS; Reymond F; Hochstrasser DF; Sanchez JC
J Proteome Res; 2006 Jul; 5(7):1674-81. PubMed ID: 16823975
[TBL] [Abstract][Full Text] [Related]
31. Atypical presentation of Creutzfeldt-Jakob disease: a rare but important cause of rapidly progressive dementia.
Taillefer MS; Tangarorang GL; Kuchel GA; Menkes DL
Conn Med; 2011 Sep; 75(8):473-8. PubMed ID: 21980678
[TBL] [Abstract][Full Text] [Related]
32. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL
Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
[TBL] [Abstract][Full Text] [Related]
33. [Analyses of 14-3-3 protein in the cerebrospinal fluid in Creutzfeldt-Jakob disease. Preliminary report].
Golańska E; Hułas-Bigoszewska K; Sikorska B; Liberski PP
Neurol Neurochir Pol; 2005; 39(5):358-65. PubMed ID: 16273459
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
Blennow K; Johansson A; Zetterberg H
Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
[TBL] [Abstract][Full Text] [Related]
35. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type.
Meissner B; Westner IM; Kallenberg K; Krasnianski A; Bartl M; Varges D; Bösenberg C; Kretzschmar HA; Knauth M; Schulz-Schaeffer WJ; Zerr I
Neurology; 2005 Nov; 65(10):1544-50. PubMed ID: 16221949
[TBL] [Abstract][Full Text] [Related]
36. Early clinical and laboratory diagnosis of Creutzfeldt-Jakob disease.
Felgenhauer K; Weber T; Poser S
Dev Biol Stand; 1993; 80():125-30. PubMed ID: 8270102
[No Abstract] [Full Text] [Related]
37. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.
Appleby BS; Appleby KK; Crain BJ; Onyike CU; Wallin MT; Rabins PV
Arch Neurol; 2009 Feb; 66(2):208-15. PubMed ID: 19204157
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
Prion; 2015; 9(2):136-43. PubMed ID: 25996401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
